MedPage Today’s gastroenterology news roundup highlighted that HelioLiver Dx showed superior sensitivity and non-inferior specificity versus ultrasound for early liver cancer detection, per the Journal of Hepatology.
Featured in MedPage Today’s gastroenterology news roundup. By Ian Ingram.
In MedPage Today’s weekly gastroenterology and hepatology news highlights, HelioLiver Dx was among the featured developments:
“Compared with ultrasound, a multi-analyte cell-free DNA-based blood test (HelioLiver Dx) demonstrated superior sensitivity and noninferior specificity for the early detection of liver cancer, including small lesions, researchers reported in the Journal of Hepatology.”
The item refers to results from the CLiMB trial, published in the Journal of Hepatology. Read our full coverage of the CLiMB publication.
Source: MedPage Today. Read the full roundup.